159 related articles for article (PubMed ID: 18196634)
1. [Results of the multicenter prospective study of cerebrolysin safety and efficacy in acute stroke].
Skwortsova VI; Stakhovskaia LV; Shamalov NA; Kerbikov OB
Zh Nevrol Psikhiatr Im S S Korsakova; 2006; Suppl 16():41-5. PubMed ID: 18196634
[TBL] [Abstract][Full Text] [Related]
2. [A randomized, double-blind, placebo-controlled study of Cerebrolysin safety and efficacy in the treatment of acute ischemic stroke].
Skvortsova VI; Stakhovskaia LV; Gubskiĭ LV; Shamalov NA; Tikhonova IV; Smychkov AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2004; (Suppl 11):51-5. PubMed ID: 15559222
[TBL] [Abstract][Full Text] [Related]
3. [The effect of cerebrolysin in dosage 50 ml on the volume of lesion in ischemic stroke].
Shamalov NA; Stakhovskaia LV; Burenchev DV; Kichuk IV; Tvorogova TV; Botsina AIu; Smychkov AS; Kerbikov OB; Moessler H; Novak P; Skvortsova VI
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12 Pt 2):34-7. PubMed ID: 21626816
[TBL] [Abstract][Full Text] [Related]
4. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial.
Heiss WD; Brainin M; Bornstein NM; Tuomilehto J; Hong Z;
Stroke; 2012 Mar; 43(3):630-6. PubMed ID: 22282884
[TBL] [Abstract][Full Text] [Related]
5. [Effectiveness of cerebrolysin in hypertensive supratentorial intracranial hemorrhages: results of a randomized triple blind placebo-controled study].
Maksimova MIu; Briukhov VV; Timerbaeva SL; Kistenev BA; Rebrova OIu; Suslina ZA
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(1):20-6. PubMed ID: 19156082
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of Cerebrolysin treatment in early recovery after acute ischemic stroke: a randomized, placebo-controlled, double-blinded, multicenter clinical trial.
Gharagozli K; Harandi AA; Houshmand S; Akbari N; Muresanu DF; Vester J; Winter S; Moessler H
J Med Life; 2017; 10(3):153-160. PubMed ID: 29075343
[No Abstract] [Full Text] [Related]
7. Neuroprotective treatment with cerebrolysin in patients with acute stroke: a randomised controlled trial.
Ladurner G; Kalvach P; Moessler H;
J Neural Transm (Vienna); 2005 Mar; 112(3):415-28. PubMed ID: 15583955
[TBL] [Abstract][Full Text] [Related]
8. Clinical Efficacy of Cerebrolysin and Cerebrolysin plus Nootropics in the Treatment of Patients with Acute Ischemic Stroke in Vietnam.
Tran L; Alvarez XA; Le HA; Nguyen DA; Le T; Nguyen N; Nguyen T; Nguyen T; Vo T; Tran T; Duong C; Nguyen H; Nguyen S; Nguyen H; Le T; Nguyen M; Nguyen T
CNS Neurol Disord Drug Targets; 2022; 21(7):621-630. PubMed ID: 34414874
[TBL] [Abstract][Full Text] [Related]
9. Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial.
Muresanu DF; Heiss WD; Hoemberg V; Bajenaru O; Popescu CD; Vester JC; Rahlfs VW; Doppler E; Meier D; Moessler H; Guekht A
Stroke; 2016 Jan; 47(1):151-9. PubMed ID: 26564102
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of Cerebrolysin in early post-stroke recovery: a meta-analysis of nine randomized clinical trials.
Bornstein NM; Guekht A; Vester J; Heiss WD; Gusev E; Hömberg V; Rahlfs VW; Bajenaru O; Popescu BO; Muresanu D
Neurol Sci; 2018 Apr; 39(4):629-640. PubMed ID: 29248999
[TBL] [Abstract][Full Text] [Related]
11. [Comparative aspects of using neuroprotectors in the management of patients with ischemic stroke].
Ershov VI
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(8 Pt 2):41-4. PubMed ID: 22224244
[TBL] [Abstract][Full Text] [Related]
12. Cerebrolysin and early neurorehabilitation in patients with acute ischemic stroke: a prospective, randomized, placebo-controlled clinical study.
Stan A; Birle C; Blesneag A; Iancu M
J Med Life; 2017; 10(4):216-222. PubMed ID: 29362596
[No Abstract] [Full Text] [Related]
13. Cerebrolysin as an Early Add-on to Reperfusion Therapy: Risk of Hemorrhagic Transformation after Ischemic Stroke (CEREHETIS), a prospective, randomized, multicenter pilot study.
Khasanova DR; Kalinin MN
BMC Neurol; 2023 Mar; 23(1):121. PubMed ID: 36973684
[TBL] [Abstract][Full Text] [Related]
14. Cerebrolysin dose-dependently improves neurological outcome in rats after acute stroke: A prospective, randomized, blinded, and placebo-controlled study.
Zhang L; Chopp M; Lu M; Zhang T; Winter S; Doppler E; Meier D; Chao L; Eapen A; Pabla P; Gang Zhang Z
Int J Stroke; 2016 Apr; 11(3):347-55. PubMed ID: 26763925
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, placebo-controlled, randomized trial to evaluate the safety and efficacy of Cerebrolysin in patients with acute ischaemic stroke in Asia--CASTA.
Hong Z; Moessler H; Bornstein N; Brainin M; Heiss WD;
Int J Stroke; 2009 Oct; 4(5):406-12. PubMed ID: 19765131
[TBL] [Abstract][Full Text] [Related]
16. Cerebrolysin adjuvant treatment in Broca's aphasics following first acute ischemic stroke of the left middle cerebral artery.
Jianu DC; Muresanu DF; Bajenaru O; Popescu BO; Deme SM; Moessler H; Meinzingen SZ; Petrica L
J Med Life; 2010; 3(3):297-307. PubMed ID: 20945821
[TBL] [Abstract][Full Text] [Related]
17. [Effects of simultaneous use of Cerebrolysin and alteplase on hemorrhagic transformation of brain infarction and functional outcome in stroke patients: CEREHETIS, a randomized, multicenter pilot trial].
Khasanova DR; Kalinin MN
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(8. Vyp. 2):60-69. PubMed ID: 37682097
[TBL] [Abstract][Full Text] [Related]
18. DP-b99, a membrane-activated metal ion chelator, as neuroprotective therapy in ischemic stroke.
Diener HC; Schneider D; Lampl Y; Bornstein NM; Kozak A; Rosenberg G
Stroke; 2008 Jun; 39(6):1774-8. PubMed ID: 18403736
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of Cerebrolysin after futile recanalisation therapy in patients with severe stroke.
Poljakovic Z; Supe S; Ljevak J; Starcevic K; Peric I; Blazevic N; Krbot-Skoric M; Jovanovic I; Ozretic D
Clin Neurol Neurosurg; 2021 Aug; 207():106767. PubMed ID: 34214867
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of Cerebrolysin in motor function recovery after stroke: a meta-analysis of the CARS trials.
Guekht A; Vester J; Heiss WD; Gusev E; Hoemberg V; Rahlfs VW; Bajenaru O; Popescu BO; Doppler E; Winter S; Moessler H; Muresanu D
Neurol Sci; 2017 Oct; 38(10):1761-1769. PubMed ID: 28707130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
